PMID- 28213569 OWN - NLM STAT- MEDLINE DCOM- 20180222 LR - 20181202 IS - 2047-9980 (Electronic) IS - 2047-9980 (Linking) VI - 6 IP - 2 DP - 2017 Feb 17 TI - Trends in Coronary Revascularization and Ischemic Heart Disease-Related Mortality in Israel. LID - 10.1161/JAHA.116.004734 [doi] LID - e004734 AB - BACKGROUND: We investigated national trends in volume and outcomes of percutaneous coronary angioplasty (PCI), coronary artery bypass grafting (CABG), and ischemic heart disease-related mortality in Israel. METHODS AND RESULTS: Using International Classification of Diseases 9th and 10th revision codes, we linked 5 Israeli national databases, including the Israel Center for Disease Control National PCI and CABG Registries, the Ministry of Health Hospitalization Report, the Center of Bureau of Statistics, and the Ministry of Interior Mortality Report, to assess the annual PCI and CABG volume, procedural mortality, comorbidities, and ischemic heart disease-related mortality between 2002 and 2014. Trends over time were analyzed using linear regression, assuming a Poisson distribution. A total of 298 390 revascularization procedures (PCI: 255 724, CABG: 42 666) were performed during the study period. PCI volume increased by 9% from 2002 to 2008 (387.4/100 000 to 423.2/100 000), steadily decreasing by 10.5% to 378.5/100 000 in 2014 (P=0.70 for the trend). CABG volume decreased by 59% (109.0/100 000 to 45.2/100 000) from 2002 to 2013, leveling at 46.4/100 000 (P<0.0001). PCI/CABG ratio increased from 3.6 in 2002 to 8.5 in 2013, slightly decreasing to 8.2 by 2014 (P<0.0001). In-hospital procedural mortality remained stable (PCI: 1.2-1.6%, P=0.34, CABG: 3.7-4.4%, P=0.29) despite a significant change in patient clinical profile. During the course of the study, ischemic heart disease-related mortality decreased by 46% (84.6-46/100 000, P<0.001). CONCLUSIONS: We observed a dramatic change in coronary revascularization procedures type and volume, and a marked decrease in ischemic heart disease-related mortality in Israel. The reasons for the observed changes remain unclear and need to be further investigated. CI - (c) 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. FAU - Blumenfeld, Orit AU - Blumenfeld O AD - Israel Centers for Disease Control, Ministry of Health, Ramat Gan, Israel orit.blumenfeld@moh.health.gov.il. FAU - Na'amnih, Wasef AU - Na'amnih W AD - Israel Centers for Disease Control, Ministry of Health, Ramat Gan, Israel. FAU - Shapira-Daniels, Ayelet AU - Shapira-Daniels A AD - Department of Cardiothoracic Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel. FAU - Lotan, Chaim AU - Lotan C AD - Department of Cardiology, Hadassah Hebrew University Medical Center, Jerusalem, Israel. FAU - Shohat, Tamy AU - Shohat T AD - Israel Centers for Disease Control, Ministry of Health, Ramat Gan, Israel. AD - Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. FAU - Shapira, Oz M AU - Shapira OM AD - Department of Cardiothoracic Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel. LA - eng PT - Journal Article PT - Multicenter Study DEP - 20170217 PL - England TA - J Am Heart Assoc JT - Journal of the American Heart Association JID - 101580524 SB - IM MH - Female MH - Hospital Mortality/trends MH - Humans MH - Israel/epidemiology MH - Male MH - Myocardial Ischemia/mortality/*surgery MH - Myocardial Revascularization/*statistics & numerical data MH - *Registries MH - Retrospective Studies MH - Treatment Outcome PMC - PMC5523769 OTO - NOTNLM OT - coronary disease OT - population OT - revascularization OT - survival EDAT- 2017/02/19 06:00 MHDA- 2018/02/23 06:00 PMCR- 2017/02/01 CRDT- 2017/02/19 06:00 PHST- 2017/02/19 06:00 [entrez] PHST- 2017/02/19 06:00 [pubmed] PHST- 2018/02/23 06:00 [medline] PHST- 2017/02/01 00:00 [pmc-release] AID - JAHA.116.004734 [pii] AID - JAH31958 [pii] AID - 10.1161/JAHA.116.004734 [doi] PST - epublish SO - J Am Heart Assoc. 2017 Feb 17;6(2):e004734. doi: 10.1161/JAHA.116.004734.